The Tumor Lysis Syndrome
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
The tumor lysis syndrome is the most common disease-related emergency in children and adults with hematologic cancers. This review summarizes current strategies for risk assessment, prophylaxis, and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An important consideration with respect to safety in patients that may have a compromised immune system is that engineered bacterial products are likely to engage both innate and adaptive immunity in the event of release of the organism into the body following tumor lysis75, triggering inflammatory responses.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [75]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D.-H., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,440
Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802639 · Cited by 1,759
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Pui, C.-H., Campana, D., Pei, D., Bowman, W. P., Sandlund, J. T., Kaste, S. C., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Onciu, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900386 · Cited by 1,215
Self-citationTumour lysis syndrome: new therapeutic strategies and classification
Cairo, M. S., & Bishop, M. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05094.x · Cited by 1,076
Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
Coiffier, B., Altman, A., Pui, C.-H., Younes, A., & Cairo, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0177 · Cited by 792
Self-citationCairo, M. S., Coiffier, B., Reiter, A., Younes, A., & Panel, O. B. O. T. T. E. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08143.x · Cited by 570
Goldman, S. C., Holcenberg, J. S., Finklestein, J. Z., Hutchinson, R., Kreissman, S., Johnson, F. L., Tou, C., Harvey, E., Morris, E., & Cairo, M. S. (2001) · Blood · doi:10.1182/blood.v97.10.2998 · Cited by 477
Cairo, M. S., Gerrard, M., Sposto, R., Auperin, A., Pinkerton, C. R., Michon, J., Weston, C., Perkins, S. L., Raphael, M., McCarthy, K., et al. (2007) · Blood · doi:10.1182/blood-2006-07-036665 · Cited by 363
Pui, C.-H., Mahmoud, H. H., Wiley, J. M., Woods, G. M., Leverger, G., Camitta, B., Hastings, C., Blaney, S. M., Relling, M. V., & Reaman, G. H. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.697 · Cited by 361
Self-citationOral Phosphate Binders in Patients with Kidney Failure
Tonelli, M., Pannu, N., & Manns, B. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912522 · Cited by 339
Cited by
Items 201–300 of 1,000
Ribrag, V., Bron, D., Rymkiewicz, G., Hoelzer, D. F., Jørgensen, J. M., de Armas‐Castellano, A., Trujillo‐Martín, M. M., Fenaux, P., Malcovati, L., Bolaños, N., et al. (2025) · The Lancet Haematology · doi:10.1016/s2352-3026(24)00351-x · Cited by 27
Spontaneous tumor lysis syndrome in patients with solid tumors: a scoping review of the literature
Papapanou, M., Athanasopoulos, A. E., Georgiadi, E. C., Maragkos, S. A., Liontos, M., Ziogas, D. C., Damaskos, D., & Schizas, D. (2023) · Medical Oncology · doi:10.1007/s12032-023-02108-4 · Cited by 27
“Rasburicase is well known for achieving a rapid and significant reduction in uric acid levels, both the newly produced and the preexisting ones [2, 97, 98].”
BackgroundInfluentialAcute Kidney Injury in Cancer Patients
Gallieni, M. A., Cosmai, L., & Porta, C. (2018) · Contributions to nephrology · doi:10.1159/000484970 · Cited by 27
Mato, A. R., Roeker, L. E., Eyre, T. A., Nabhan, C., Lamanna, N., Hill, B. T., Brander, D. M., Barr, P. M., Lansigan, F., Cheson, B. D., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000180 · Cited by 27
“Investigators were asked to define TLS events by Howard criteria.(12) Response rates were defined by International Workshop on Chronic Lymphocytic Leukemia criteria as complete remission (CR), partial remission, stable disease, and progressive disease.”
MethodJakobsen, L. H., Ellin, F., Smeland, K. B., Wästerlid, T., Christensen, J. H., Jørgensen, J. M., Josefsson, P. L., Øvlisen, A. K., Holte, H., Blaker, Y. N., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16425 · Cited by 26
“Clinical tumour lysis was classified using established criteria (Howard et al., 2011).”
MethodClinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemia
Xue, Y., Chen, J., Gao, S., Zhai, X., Wang, N., Gao, J., Lv, Y., Yin, M., Zhuang, Y., Zhang, H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-88912-2 · Cited by 26
Tumor Lysis Syndrome: Risk Factors, Diagnosis, and Management
Burns, R. A., Topoz, I., & REYNOLDS, S. L. (2014) · Pediatric Emergency Care · doi:10.1097/pec.0000000000000195 · Cited by 26
Zhang, L., Steele, M. B., Jenks, N. J., Grell, J. A., Behrens, M. D., Nace, R. A., Naik, S., Federspiel, M. J., Russell, S. J., & Peng, K.-W. (2016) · Molecular Therapy · doi:10.1038/mt.2016.167 · Cited by 26
Immune Checkpoint Inhibitor–Associated Tumor Lysis Syndrome: A Real-World Pharmacovigilance Study
Wang, L., Li, X., Zhao, B., Mei, D., Jiang, J., & Duan, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.679207 · Cited by 25
“Tumor lysis syndrome (TLS) is a life-threatening condition that can occur whenmassive malignant cells die and break down quickly, releasing large amounts of nucleic acids, phosphate, potassium, and cytokines into the circulatory system either spontaneously or in response to treatment (Cairo et al., 2010; Howard et al.…”
BackgroundInfluentialHematology Emergencies in Adults With Critical Illness
Spring, J. L., & Munshi, L. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.02.004 · Cited by 25
Tumor lysis syndrome in the emergency department: challenges and solutions
Ñamendys-Silva, S. A., Arredondo-Armenta, J. M., Plata-Menchaca, E. P., Guevara-García, H., García-Guillén, F. J., Rivero-Sigarroa, E., & Herrera‐Gómez, Á. (2015) · Open Access Emergency Medicine · doi:10.2147/oaem.s73684 · Cited by 25
Impact of dialysis requirement on outcomes in tumor lysis syndrome
Garimella, P. S., Balakrishnan, P., Ammakkanavar, N. R., Patel, S., Patel, A., Konstantinidis, I., Annapureddy, N., & Nadkarni, G. N. (2016) · Nephrology · doi:10.1111/nep.12806 · Cited by 25
Spontaneous Tumor Lysis Syndrome in Diffuse Large B-cell Lymphoma: Early Diagnosis and Management
Gangireddy, M., Shrimanker, I., Nookala, V., & Peroutka, K. A. (2019) · Cureus · doi:10.7759/cureus.4679 · Cited by 25
“All these manifestations can eventually lead to multiple organ failure [4].”
BackgroundMartens, K. L., Khalighi, P. R., Li, S., White, A. A., Silgard, E. T., Frieze, D. A., Estey, E. H., Garcia, D. A., Hingorani, S. R., & Li, A. (2020) · Leukemia Research · doi:10.1016/j.leukres.2020.106298 · Cited by 25
Koehler, A. B., Leung, N., Call, T. G., Rabe, K. G., Achenbach, S. J., Ding, W., Kenderian, S. S., Leis, J. F., Wang, Y., Muchtar, E., et al. (2020) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2020.1768384 · Cited by 25
Arnst, J. L., & Beck, G. R. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114305 · Cited by 25
CAR-T cell therapy: practical guide to routine laboratory monitoring
Selim, A. G., Minson, A. G., Blombery, P. A., Dickinson, M. J., Harrison, S. J., & Anderson, M. A. (2021) · Pathology · doi:10.1016/j.pathol.2021.02.002 · Cited by 25
Fluid Stewardship of Maintenance Intravenous Fluids
Carr, J., Hawkins, W. A., Sikora, A. N., Smith, S. E., Clemmons, A. B., Bland, C. M., & Branan, T. N. (2021) · Journal of Pharmacy Practice · doi:10.1177/08971900211008261 · Cited by 25
“reasonable once laboratory abnormalities are normalized on two consecutive measurements with ongoing monitoring for at least 24 hours.(144,145)”
BackgroundMethodLyons, P. G., Klaus, J., McEvoy, C. A., Westervelt, P., Gage, B. F., & Kollef, M. H. (2019) · Journal of Oncology Practice · doi:10.1200/jop.18.00765 · Cited by 26
Yang, B. Y., Lu, X.-C., Yu, R., Zhang, W.-Y., Zhu, H.-L., Chi, X.-H., Yuan, J., & Zhao, P. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318244db6f · Cited by 25
Russell, T. B., & Kram, D. E. (2020) · Pediatrics in Review · doi:10.1542/pir.2018-0243 · Cited by 24
CAR T-Cell Therapy: Updates in Nursing Management
Baer, B. (2021) · Clinical journal of oncology nursing · doi:10.1188/21.cjon.255-258 · Cited by 24
Imaging of acute and subacute toxicities of cancer therapy in children
Chavhan, G. B., Babyn, P., Nathan, P. C., & Kaste, S. C. (2015) · Pediatric Radiology · doi:10.1007/s00247-015-3454-1 · Cited by 24
“Children with tumor lysis syndrome are predisposed to life-threatening cardiac arrhythmias, seizures and metabolic acidosis [52].”
BackgroundChronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents
Galitzia, A., Maccaferri, M., Mauro, F. R., Murru, R., & Marasca, R. (2024) · Cancers · doi:10.3390/cancers16111996 · Cited by 23
Oxidative stress in sickle cell disease; more than a DAMP squib
van Beers, E. J., & van Wijk, R. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189010 · Cited by 23
“In its xanthine oxidase form it functions as a superoxide producing enzyme that among others is involved in the metabolic breakdown of adenosine and guanosine into uric acid [45].”
Review of oncological emergencies in small animal patients
Tumielewicz, K. L., Hudak, D., Kim, J., Hunley, D. W., & Murphy, L. A. (2019) · Veterinary Medicine and Science · doi:10.1002/vms3.164 · Cited by 23
“insufficiency, oliguria, dehydration, hypotension and acidic urine (Howard et al. 2011).”
BackgroundMethodInfluentialPelcovits, A., Moore, J. W., Bakow, B. R., Niroula, R., Egan, P., & Reagan, J. L. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06119-7 · Cited by 23
“Using the Cairo-Bishop criteria as modified by Howard, we examined the number of episodes of laboratory or clinical tumor lysis in all patients [14].”
MethodMansouri, V., Yazdanpanah, N., & Rezaei, N. (2021) · International Reviews of Immunology · doi:10.1080/08830185.2021.1984449 · Cited by 23
Oncologic Metabolic Emergencies
Wagner, J. G., & Arora, S. (2014) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2014.04.003 · Cited by 23
Pediatric Oncologic Emergencies
Stephanos, K., & Picard, L. (2018) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2018.04.007 · Cited by 23
Phosphatidylserine externalization as immune checkpoint in cancer
Kur, I.-M., & Weigert, A. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-02948-7 · Cited by 22
Vu, H. T., Kotla, S., Ko, K. A., Fujii, Y., Tao, Y., Medina, J., Thomas, T. N., Hada, M., Sood, A. K., Singh, P. K., et al. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00023 · Cited by 22
“In this study, we focused on the direct effects of IR on ECs, but it is possible that the contents in tumor cells such as electrolytes and DNA are released after cancer treatment, which then indirectly causes metabolic disturbance and cardiovascular toxicity (42).”
Sala-Cunill, A., Luengo, O., & Cardona, V. (2019) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000550 · Cited by 22
Schiff, J. P., Spraker, M. B., Duriseti, S., Shaikh, S. J., Murad, H. F., Mutch, D. G., Robinson, C. G., Kavanaugh, J., & Lin, A. J. (2021) · Advances in Radiation Oncology · doi:10.1016/j.adro.2021.100797 · Cited by 22
“Nevertheless, a slower, radiation-induced “smoldering TLS” would be consistent with the typical slower radiographic responses seen with ablative radiation.30−32 Patients due to receive therapy for malignancy should be risk stratified for TLS. Predictive factors include type and burden of malignancy, anticipated respon…”
BackgroundInfluentialGri, N., Longhitano, Y., Zanza, C., Monticone, V., Fuschi, D., Piccioni, A., Bellou, A., Esposito, C., Ceresa, I. F., & Savioli, G. (2023) · Current Oncology · doi:10.3390/curroncol30080531 · Cited by 22
“However, the presence of intracranial hypertension markedly worsens the prognosis, with a median survival of 3 months and a one-year survival of 10% [35,37,41,42].”
BackgroundLow-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient
Kim, J. O., Jun, D. W., Tae, H. J., Lee, K. N., Lee, H. L., Lee, O. Y., Choi, H. S., Yoon, B. C., & Hahm, J. S. (2015) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2015.21.1.85 · Cited by 22
“are released, the severe alteration of these metabolic profiles can have clinically toxic effects, including acute kidney injury, cardiac arrhythmias, seizures, and multiorgan failure that can finally result in death.(6) Although it most often happens in hematologic malignancies such as acute lymphocytic leukemia and…”
BackgroundAcute kidney injury in hematological patients
Canet, E., Vincent, F., Darmon, M., & Soares, M. (2015) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000253 · Cited by 22
“TLS-induced AKI is related to crystallization of urate and calcium phosphate in the kidney, but also to other mechanisms (renal vasoconstriction, impaired autoregulation, oxidation, and inflammation) [56].”
BackgroundSíndrome de lisis tumoral en neoplasias sólidas: características clínicas y pronóstico
Caravaca‐Fontán, F., Martínez‐Sáez, O., Pampa‐Saico, S., Olmedo, M. E., Gomis, A., & Garrido, P. (2016) · Medicina Clínica · doi:10.1016/j.medcli.2016.10.040 · Cited by 22
Pathogenesis and Treatment of Nephrolithiasis
Coe, F. L., Evan, A. P., & Worcester, E. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00067-7 · Cited by 22
Wen, P., Ai, Q., Fan, X., Gu, Z., 陈波, & Qian, H. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218257 · Cited by 21
Urgent chemotherapy in hematological patients in the ICU
Moors, I., Pène, F., Lengliné, É., & Benoît, D. (2015) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000254 · Cited by 21
“The risk and extent of TLS is dependent on the grade of malignancy (high-grade lymphoma and acute leukemia), the tumor burden and the susceptibility to anti-cancer treatments [24].”
BackgroundDeochand, D. K., Perera, I. C., Crochet, R. B., Gilbert, N. C., Newcomer, M. E., & Grove, A. (2016) · Molecular BioSystems · doi:10.1039/c6mb00304d · Cited by 21
Almanza, E., Espinosa-Bautista, K. A., Rangel‐Patiño, J., & Demichelis‐Gómez, R. (2020) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2020.07.017 · Cited by 21
Izutsu, K., Yamamoto, K., Kato, K., Ishikawa, T., Fukuhara, N., Terui, Y., Choi, I., Humphrey, K., Kim, S. Y., Okubo, S., et al. (2020) · International Journal of Hematology · doi:10.1007/s12185-020-03024-3 · Cited by 21
The toxicity of cell therapy: Mechanism, manifestations, and challenges
Jin, Y., Dong, Y., Jin, Z., Sun, J., Liu, Y., & Chen, Y. (2020) · Journal of Applied Toxicology · doi:10.1002/jat.4100 · Cited by 21
Arora, S., Zainaldin, C., Bathini, S., Gupta, U., Worth, S., Bachiashvili, K., Bhatia, R., Godby, K. N., JAMY, O. H., Rangaraju, S., et al. (2022) · Leukemia Research · doi:10.1016/j.leukres.2022.106844 · Cited by 21
Tumor lysis syndrome and malignant melanoma
Mouallem, M., Zemer‐Wassercug, N., Kugler, E., Sahar, N., Shapira‐Frommer, R., & Schiby, G. (2013) · Medical Oncology · doi:10.1007/s12032-012-0364-z · Cited by 21
Yainoy, S., Phuadraksa, T., Wichit, S., Sompoppokakul, M., Songtawee, N., Prachayasittikul, V., & Isarankura‐Na‐Ayudhya, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061269 · Cited by 21
“Such high level of uric acid usually leads to precipitation of urate crystals in the renal tubules and eventually leads to acute kidney failure [10].”
BackgroundPui, C. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633.014 · Cited by 21
Self-citationManaging tumor lysis syndrome in 2010
Gertz, M. A. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190903488788 · Cited by 21
Thongprayoon, C., Cheungpasitporn, W., Mao, M. A., Harrison, A. M., & Erickson, S. B. (2019) · Hospital Practice · doi:10.1080/21548331.2019.1568719 · Cited by 20
“Aggressive calcium replacement for TLS and rhabdomyolysis patients with hypocalcemia is discouraged given the higher risk of calcium phosphate induced organ injury and calcium phosphate deposition in the renal tubules [55].”
BackgroundMalignancy diseases and kidneys: A nephrologist prospect and updated review
Habas, E. M., Akbar, R. A., Farfar, K., Arrayes, N., Habas, A., Rayani, A., Alfitori, G. B., Habas, E., Magassabi, Y., Ghazouani, H., et al. (2023) · Medicine · doi:10.1097/md.0000000000033505 · Cited by 20
“[75,76] Uric acid, xanthine, and calcium phosphate crystal precipitation in renal tubules are one of the main mechanisms of TLS-induced AKI.”
BackgroundLei, M. M., Sorial, M. N., Lou, U. Y., Yu, M. A., Medrano, A., Ford, J. G., Nemec, R. A., Abramson, J. S., & Soumerai, J. D. (2024) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2024.2310144 · Cited by 20
“Clinical and laboratory TLS were classified using the Howard criteria [7].”
MethodA tumour lysis syndrome in a chemotherapy naïve patient with metastatic pancreatic adenocarcinoma
Saleh, R., Rodrigues, J., & Lee, T. C. (2015) · BMJ Case Reports · doi:10.1136/bcr-2014-207748 · Cited by 20
Li, P., Liu, Y., Liang, Y., Bo, J., Gao, S., Hu, Y., Hu, Y., Huang, H., Huang, X., Jing, H., et al. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0585 · Cited by 20
Kim, H. D., Ha, K. S., Woo, I. S., Jung, Y. H., Han, C. W., & Kim, T. J. (2014) · Cancer Research and Treatment · doi:10.4143/crt.2014.46.2.204 · Cited by 20
Rajendran, A., Bansal, D., Marwaha, R. K., & Singhi, S. C. (2012) · The Indian Journal of Pediatrics · doi:10.1007/s12098-012-0824-7 · Cited by 20
Seymour, J. F. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2695-x · Cited by 20
Venetoclax‐induced tumour lysis syndrome in acute myeloid leukaemia
Esparza, S., Muluneh, B., Galeotti, J., Matson, M., Richardson, D. R., Montgomery, N. D., Coombs, C. C., Jamieson, K. J., Foster, M. C., & Zeidner, J. F. (2019) · British Journal of Haematology · doi:10.1111/bjh.16235 · Cited by 20
Managing Hyperkalemia in the Modern Era: A Case-Based Approach
Massicotte‐Azarniouch, D., Canney, M., Sood, M. M., & Hundemer, G. L. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.04.016 · Cited by 19
Higher serum phosphorus is associated with catabolic/anabolic imbalance in heart failure
Rozentryt, P., Niedziela, J. T., Hudzik, B., Lekston, A., Doehner, W., Jankowska, E. A., Nowak, J. U., von Haehling, S., Partyka, R., Rywik, T. M., et al. (2015) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12026 · Cited by 19
“syndrome where hyperphosphatemia associated with hyperuricaemia and inflammation is a typical laboratory finding.(4) It is not known if mild forms of this syndrome may occur in HF, although similarities of biochemical profiles between tumour lysis and acute HF are striking.”
Howard, S. C., Pui, C., & Ribeiro, R. C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415948-8.00004-0 · Cited by 19
Self-citationMaji, A., Majee, P., Singha, D. K., Ghosh, A. K., Mondal, S. K., & Mahata, P. (2018) · Journal of Photochemistry and Photobiology A Chemistry · doi:10.1016/j.jphotochem.2018.07.033 · Cited by 19
Gopakumar, K. G., Seetharam, S., Krishna, K. M. J., Nair, M., Rajeswari, B., Guruprasad, C. S., Prasanth, V. R., & Thankamony, P. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27401 · Cited by 19
Hunger, S. P., Teachey, D. T., Grupp, S. A., & Aplenc, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00093-1 · Cited by 19
Controlling serum uric acid using febuxostat in cancer patients at risk of tumor lysis syndrome
Takai, M., Yamauchi, T., Fujita, K., Lee, S., Ookura, M., Kishi, S., Urasaki, Y., Yoshida, A., Iwasaki, H., & Ueda, T. (2014) · Oncology Letters · doi:10.3892/ol.2014.2394 · Cited by 19
“TLS can also occur spontaneously in the context of any cancer associated with high proliferation and/or a large tumor burden (1-4).”
Zhang, Y., Zhang, W., Dai, H., Wang, Y., Shi, F., Wang, C., Guo, Y., Liu, Y., Chen, M., Feng, K., et al. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-5035-4 · Cited by 19
“To our surprise, however, this patient presented with severe tumor lysis syndrome (TLS) and achieved complete remission again only after an intrathecal injection of cytarabine (50 mg), methotrexate (10 mg), and dexamethasone (5 mg).”
InfluentialTumour lysis syndrome in solid tumors: Clinical characteristics and prognosis
Caravaca‐Fontán, F., Martínez‐Sáez, O., Pampa‐Saico, S., Olmedo, M. E., Gomis, A., & Garrido, P. (2017) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2016.10.048 · Cited by 19
Villas, J. M. C. (2019) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2019.03.006 · Cited by 19
Spontaneous Tumor Lysis Syndrome
Wesemüller, W., & Taverna, C. (2020) · Case Reports in Oncology · doi:10.1159/000509643 · Cited by 19
Uric Acid and Acute Kidney Injury in the Critically Ill
Srivastava, A., Pálsson, R., Leaf, D. E., Higuera, A., Chen, M. E., Palacios, P., Baron, R. M., Sabbisetti, V. S., Hoofnagle, A. N., Vaingankar, S. M., et al. (2019) · Kidney Medicine · doi:10.1016/j.xkme.2019.01.003 · Cited by 18
“8%) APACHE II score 26 [21-31] 25 [21-31] 27 [22-32] 26 [22-31] SOFA cardiovascular score 0-2 102 (40.”
Chan, J. S., Baker, S. L., & Bernard, A. W. (2012) · BMJ Case Reports · doi:10.1136/bcr.12.2011.5330 · Cited by 18
Dar, L., Gendelman, O., & Amital, H. (2014) · PubMed · Cited by 18
Phosphorus binders: The new and the old, and how to choose
Sekar, A., Kaur, T., Nally, J. V., Rincon-Choles, H., Jolly, S. E., & Nakhoul, G. (2018) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.85a.17054 · Cited by 18
Chimeric Antigen Receptor (CAR) T Cell Therapy for Cancer. Challenges and Opportunities: An Overview
Cortés-Hernández, A., Alvarez-Salazar, E. K., & Soldevila, G. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0759-6_14 · Cited by 18
Evaluation of Acute Kidney Injury in the Hospital Setting
Eftekhari, P. (2014) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2014.08.005 · Cited by 19
Sekiguchi, N., Joshita, S., Yoshida, T., Kurozumi, M., Sano, K., Nakagawa, M., Ito, T., Matsushita, T., Komatsu, D. D., Komatsu, M., et al. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.0278 · Cited by 18
“The patient was immediately started on a modified CHOP regimen (1,200 mg cyclophosphamide, day 1; 80 mg doxorubicin, day 1; 60 mg PSL, days 1-5; vincristine was not administered due to severe neuropathy), and special attention was paid to the possibility of tumor lysis syndrome (5, 6).”
MethodHunger, S. P., & Antillon, F. G. (2013) · Springer eBooks · doi:10.1007/978-1-4614-3891-5_16 · Cited by 18
Manda, S., Anz, B. M., Benton, C. B., Broun, E. R., Yimer, H. A., Renshaw, J. S., Geils, G. F., Berdeja, J. G., Cruz, J. C., Melear, J. M., et al. (2024) · Hematological Oncology · doi:10.1002/hon.3274 · Cited by 17
Xiao, X., Sun, Z., Ji, X., Lin, H., Jing, H., & Yu, Q. (2024) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2024.07.005 · Cited by 17
The confused oncologic patient: a rational clinical approach
Nolan, C. P., & DeAngelis, L. M. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000392 · Cited by 17
Martin, T. G., Mikhael, J. R., Hájek, R., Kım, K., Suzuki, K., Hulin, C., Garg, M. K., Quach, H., Sia, H., George, A., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006713 · Cited by 17
“025 g/dL.(21,22) The threshold for M-protein positivity in the mass spectrometry assay was determined at 0.”
BackgroundOutcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis
Haddad, F., Sasaki, K., Senapati, J., Xiao, L., Park, G. S., Abuasab, T., Venugopal, S., Rivera, D., Bazinet, A., Babakhanlou, R., et al. (2024) · JCO Oncology Practice · doi:10.1200/op.24.00027 · Cited by 17
“19,20”
Exchange transfusion in patients with Down syndrome and severe transient leukemia
Hayasaka, I., Cho, K., Morioka, K., Kaneshi, Y., Akimoto, T., Furuse, Y., Moriichi, A., Iguchi, A., Cho, Y., Minakami, H., et al. (2015) · Pediatrics International · doi:10.1111/ped.12586 · Cited by 17
Spontaneous Tumor Lysis Syndrome in Small-Cell Lung Cancer: A Rare Complication!
Weerasinghe, C. K., Zaarour, M., Aranout, S., Garcia, G., & Dhar, M. (2015) · World Journal of Oncology · doi:10.14740/wjon946w · Cited by 17
“Other potential risk factors for STLS in solid tumors include increased tumor burden, evidence of large-sized masses and lymph node involvement, pre-existing hyperuricemia, elevated LDH, metastatic disease (especially liver and bone metastases), and external compression of the urinary tract leading to azotemia [5, 37-…”
BackgroundA Case of Spontaneous Tumor Lysis Syndrome in Malignant Melanoma
Takeuchi, N., Miyazawa, S., Ohno, Z., Yoshida, S., Tsukamoto, T., & Fujiwara, M. (2016) · World Journal of Oncology · doi:10.14740/wjon970w · Cited by 17
“Tumor lysis syndrome (TLS) is a critical condition involving oncological emergency and usually appears after the administration of treatments associated with massive tumor cell death [1].”
BackgroundRational use of rasburicase for the treatment and management of tumor lysis syndrome
Shaikh, S. A., Marini, B. L., Hough, S. M., & Perissinotti, A. J. (2017) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155216687152 · Cited by 17
“Recently in 2014, however, a guideline was developed at the institution to optimize the management of this complication based on patient risk factors and stratified uric acid levels adopted from literature, including preexisting renal dysfunction, elevated uric acid, lactate dehydrogenase (LDH), and white blood cell c…”
BackgroundZhou, P., Sun, L., Shao, L., Yi, L., Li, N., & Fan, X. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i31.4607 · Cited by 17
Barr, P. M., Tedeschi, A., Wierda, W. G., Allan, J. N., Ghia, P., Vallisa, D., Jacobs, R. W., O'Brien, S. M., Grigg, A., Walker, P., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0504 · Cited by 16
“5 10(9)/L 14 (9) 13 (8) 27 (8) Hierarchical cytogenetics classification, n (%)”
BackgroundInfluentialTri-specific killer engager: unleashing multi-synergic power against cancer
Winidmanokul, P., Panya, A., & Okada, S. (2024) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2024.00227 · Cited by 16
Dubbs, S. B. (2018) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2018.04.003 · Cited by 16
Acute Kidney Injury in Patients With Cancer: A Review of Onconephrology
Gudsoorkar, P. S., Langote, A., Vaidya, P., & Meraz-Muñoz, A. (2021) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2021.09.008 · Cited by 16
Canet, E., Cheminant, M., Zafrani, L., Thiéblemont, C., Galicier, L., Lengliné, É., Schnell, D., Reuter, D., Darmon, M., Schlemmer, B., et al. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.874010 · Cited by 16
Wierda, W. G., Byrd, J. C., Davids, M. S., Furman, R. R., Cheson, B. D., Barr, P. M., Eradat, H. A., Heffner, L. T., Zhou, L., Verdugo, M., et al. (2018) · British Journal of Haematology · doi:10.1111/bjh.15666 · Cited by 16
Fluid overload and acute kidney injury in children with tumor lysis syndrome
Flood, K., Rozmus, J., Skippen, P. W., Matsell, D. G., & Mammen, C. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29255 · Cited by 16
Systemic Adverse Events with Biomedicines
Tridente, G. (2014) · Cited by 15
Postoperative Übelkeit und Erbrechen – Handlungsempfehlungen zur Prävention und Therapie bei Kindern
Schlesinger, T., Becke, K., Eich, C. B., Gottschaldt, U., Kretz, F., Krösche, J., Kranke, P., & Höhne, C. (2023) · Die Anaesthesiologie · doi:10.1007/s00101-022-01248-y · Cited by 15
Immunotherapy-associated hemostatic abnormalities: bleeding and thrombotic complications
Li, Y., Jiang, H., Luo, L., & Mei, H. (2025) · Annals of Hematology · doi:10.1007/s00277-025-06482-z · Cited by 15
“1) [34, 83, 84 ].”
Spontaneous Tumor Lysis Syndrome in a Patient with Metastatic Hepatocellular Carcinoma
Mehrzad, R., Saito, H., Krahn, Z., & Feinstein, A. (2014) · Medical Principles and Practice · doi:10.1159/000360362 · Cited by 15
Bulky Solid Tumors in Elderly Adults: Beware of Spontaneous Tumor Lysis Syndrome
Gbaguidi, X., Goodrich, L., Roca, F., Suel, P., & Chassagne, P. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13901 · Cited by 15
“There is female predominance (estimated female:male ratio 6:4).(1) In the majority of reported cases of eyelid melanoma, the tumor is located in the lower eyelid,(4) as in this case.”
BackgroundInfluential
Metadata
- Authors
- Howard, S. C., Jones, D. P., & Pui, C.-H.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-05-12
- Volume
- 364
- Issue
- 19
- Pages
- 1844-1854
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3437249
- OpenAlex
- W2122479144
- Cited by
- 1,044
- References
- 58
- Citations by year
- 2026: 71 · 2025: 67 · 2024: 86 · 2023: 71 · 2022: 69 · 2021: 81 · 2020: 89 · 2019: 154 · 2018: 60 · 2017: 53 · 2016: 49 · 2015: 57 · 2014: 47 · 2013: 49 · 2012: 31
- FWCI
- 36.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA21765, P30CA021765)
- National Institute of General Medical Sciences (U01GM92666, U01GM092666)
- Topics
- Health Sciences › Medicine › Hematology › Methemoglobinemia and Tumor Lysis Syndrome
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Health Sciences › Medicine › Surgery › Muscle and Compartmental Disorders
- Keywords
- tumor lysis syndrome, hematologic malignancies, risk assessment, prophylaxis, treatment, pediatric oncology, emergency management
- MeSH terms
- Child, Humans, Male, Tumor Lysis Syndrome, Risk Assessment, Acute Kidney Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.